The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
CD1 molecules belong to non-polymorphic MHC class I-likeproteins and present lipid antigens to T cells. Five differentCD1 genes (CD1a-e) have been identified and classified intotwo groups. Group 1 include CD1a-c and present pathogeniclipid antigens to αβ T cells reminiscence of peptide antigenpresentation by MHC-I molecules. CD1d is the only memberof Group 2 and presents foreign and self lipid antigens to aspecialized subset of αβ T cells, NKT cells. NKT cells areinvolved in diverse immune responses through prompt andmassive production of cytokines. CD1d-dependent NKT cellsare categorized upon the usage of their T cell receptors. Amajor subtype of NKT cells (type I) is invariant NKT cellswhich utilize invariant Vα14-Jα18 TCR alpha chain in mouse. The remaining NKT cells (type II) utilize diverse TCR alphachains. Engineered CD1d molecules with modified intracellulartrafficking produce either type I or type II NKT celldefectssuggesting the lipid antigens for each subtypes of NKTcells are processed/generated in different intracellular compartments. Since the usage of TCR by a T cell is the result ofantigen-driven selection, the intracellular metabolic pathwaysof lipid antigen are a key in forming the functional NKT cell repertoire.
Abstract
CD1 molecules belong to non-polymorphic MHC class I-likeproteins and present lipid antigens to T cells. Five differentCD1 genes (CD1a-e) have been identified and classified intotwo groups. Group 1 include CD1a-c and present pathogeniclipid antigens to αβ T cells reminiscence of peptide antigenpresentation by MHC-I molecules. CD1d is the only memberof Group 2 and presents foreign and self lipid antigens to aspecialized subset of αβ T cells, NKT cells. NKT cells areinvolved in diverse immune responses through prompt andmassive production of cytokines. CD1d-dependent NKT cellsare categorized upon the usage of their T cell receptors. Amajor subtype of NKT cells (type I) is invariant NKT cellswhich utilize invariant Vα14-Jα18 TCR alpha chain in mouse. The remaining NKT cells (type II) utilize diverse TCR alphachains. Engineered CD1d molecules with modified intracellulartrafficking produce either type I or type II NKT celldefectssuggesting the lipid antigens for each subtypes of NKTcells are processed/generated in different intracellular compartments. Since the usage of TCR by a T cell is the result ofantigen-driven selection, the intracellular metabolic pathwaysof lipid antigen are a key in forming the functional NKT cell repertoire.
참고문헌 (71)
- Rock, K. L., "Protein degradation and the generation of MHC class I-presented peptides", Adv. Immunol, 80, pp.1~70 (2002)
- Hiltbold, E. M, "Trafficking of MHC class II molecules in the late secretory pathway", Curr. Opin. Immunol, 14, pp.30~35 (2002)
- Porcelli, S. A., "The CD1 family: a third lineage of antigen-presenting molecules", Adv. Immunol, 59, pp.1~98 (1995)
- Calabi, F., "Two classes of CD1 genes", Eur. J. Immunol, 19, pp.285~292 (1989)
- de la Salle, H., "Assistance of microbial glycolipid antigen processing by CD1e", Science, 310, pp.1321~1324 (2005)
- Moody, D. B., "T cell activation by lipopeptide antigens", Science, 303, pp.527~531 (2004)
- Beckman, E. M., "Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells", Nature, 372, pp.691~694 (1994)
- Sieling, P. A., "CD1-restricted T cell recognition of microbial lipoglycan antigens", Science, 269, pp.227~230 (1995)
- Shamshiev, A., "The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides", Immunity, 13, pp.255~264 (2000)
- Moody, D. B., "CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection", Nature, 404, pp.884~888 (2000)
- Matsunaga, I., "Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells", J. Exp. Med, 200, pp.1559~1569 (2004)
- Wu, D. Y., "Cross-presentation of disialoganglioside GD3 to natural killer T cells", J. Exp. Med, 198, pp.173~181 (2003)
- Kawano, T., "CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides", Science, 278, pp.1626~1629 (1997)
- Brigl, M., "CD1: antigen presentation and T cell function", Annu. Rev. Immunol, 22, pp.817~890 (2004)
- Barral, D. C., "CD1 antigen presentation: how it works", Nat. Rev. Immunol, 7, pp.929~941 (2007)
- Bendelac, A., "The biology of NKT cells", Annu. Rev. Immunol, 25, pp.297~336 (2007)
- Zeng, Z., "Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove", Science, 277, pp.339~345 (1997)
- Borg, N. A., "CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor", Nature, 448, pp.44~49 (2007)
- Geissmann, F., "Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids", PLoS Biol, 3, pp.e113~ (2005)
- Thomas, S. Y., "PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions", J. Exp. Med, 208, pp.1179~1188 (2011)
- Ohteki, T., "Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways", J. Immunol, 162, pp.3753~3756 (1999)
- Blomqvist, M., "Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells", Eur. J. Immunol, 39, pp.1726~1735 (2009)
- Zhang, G., "Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma", Am. J. Physiol. Lung Cell Mol. Physiol, 301, pp.975~984 (2011)
- Halder, R. C., "Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease", J. Clin. Invest, 117, pp.2302~2312 (2007)
- Ambrosino, E., "Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis", J. Immunol, 179, pp.5126~5136 (2007)
- Lu, X., "Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells", Chembiochem, 7, pp.1750~1756 (2006)
- Wipf, P., "Expedient synthesis of the alpha-C-glycoside analogue of the immunostimulant galactosylceramide (KRN7000)", Org. Lett, 8, pp.3375~3378 (2006)
- Yang, G., "The C-glycoside analogue of the immunostimulant alpha- galactosylceramide (KRN7000): synthesis and striking enhancement of activity", Angew. Chem. Int. Ed. Engl, 43, pp.3818~3822 (2004)
- Schmieg, J., "Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide", J. Exp. Med, 198, pp.1631~1641 (2003)
- Oki, S., "Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo", Int. Immunol, 17, pp.1619~1629 (2005)
- Yu, K. O., "Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides", Proc. Natl. Acad. Sci. U. S. A, 102, pp.3383~3388 (2005)
- Kinjo, Y., "Recognition of bacterial glycosphingolipids by natural killer T cells", Nature, 434, pp.520~525 (2005)
- Mattner, J., "Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections", Nature, 434, pp.525~529 (2005)
- Kinjo, Y., "Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria", Nat. Immunol, 7, pp.978~986 (2006)
- Amprey, J. L., "A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan", J. Exp. Med, 200, pp.895~904 (2004)
- Bendelac, A., "Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes", J. Exp. Med, 182, pp.2091~2096 (1995)
- Bendelac, A., "CD1: presenting unusual antigens to unusual T lymphocytes", Science, 269, pp.185~186 (1995)
- Exley, M., "Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells", J. Exp. Med, 186, pp.109~120 (1997)
- Bendelac, A., "A subset of CD4+ thymocytes selected by MHC class I molecules", Science, 263, pp.1774~1778 (1994)
- Zhou, D., "Lysosomal glycosphingolipid recognition by NKT cells", Science, 306, pp.1786~1789 (2004)
- Porubsky, S., "Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency", Proc. Natl. Acad. Sci. U. S. A, 104, pp.5977~5982 (2007)
- Gumperz, J. E., "Murine CD1d-restricted T cell recognition of cellular lipids", Immunity, 12, pp.211~221 (2000)
- Facciotti, F., "Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus", Nat. Immunol, 13, pp.474~480 (2012)
- Shamshiev, A., "Presentation of the same glycolipid by different CD1 molecules", J. Exp. Med, 195, pp.1013~1021 (2002)
- Jahng, A., "Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide", J. Exp. Med, 199, pp.947~957 (2004)
- Arrenberg, P., "Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta- linked self-glycolipid", Proc. Natl. Acad. Sci. U. S. A, 107, pp.10984~10989 (2010)
- Kang, S. J, "Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain", J. Biol. Chem, 277, pp.44838~44844 (2002)
- Hughes, E. A, "The thiol oxidoreductase ERp57 is a component of the MHC class I peptide- loading complex", Current biology, 8, pp.709~712 (1998)
- Morrice, N. A, "A role for the thiol- dependent reductase ERp57 in the assembly of MHC class I molecules", Current biology: CB, 8, pp.713~716 (1998)
- Dougan, S. K., "Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells", J. Exp. Med, 202, pp.529~539 (2005)
- Brozovic, S., "CD1d function is regulated by microsomal triglyceride transfer protein", Nat. Med, 10, pp.535~539 (2004)
- Cernadas, M., "Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development", J. Immunol, 171, pp.4149~4155 (2003)
- Elewaut, D., "The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells", J. Exp. Med, 198 (2003)
- Lawton, A. P., "The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms", J. Immunol, 174, pp.3179~3186 (2005)
- Salio, M., "Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation", Proc. Natl. Acad. Sci. U. S. A, 110, pp.4753~4761 (2013)
- Kang, S. J., "Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells", Nat. Immunol, 5, pp.175~181 (2004)
- Yuan, W., "Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules", Proc. Natl. Acad. Sci. U. S. A, 104, pp.5551~5556 (2007)
- Zhou, D., "Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins", Science, 303, pp.523~527 (2004)
- Sugita, M., "Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells", Immunity, 16, pp.697~706 (2002)
- Jayawardena-Wolf, J., "CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain", Immunity, 15, pp.897~908 (2001)
- Chiu, Y. H., "Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments", J. Exp. Med, 189, pp.103~110 (1999)
- Chiu, Y. H., "Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d", Nat. Immunol, 3, pp.55~60 (2002)
- Prigozy, T. I., "Glycolipid antigen processing for presentation by CD1d molecules", Science, 291, pp.664~667 (2001)
- Bai, L., "Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer", Proc. Natl. Acad. Sci. U. S. A, 106, pp.10254~10259 (2009)
- Im, J. S., "Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation", Immunity, 30, pp.888~898 (2009)
- Shin, J. H., "Mutation of a positively charged cytoplasmic motif within CD1d results in multiple defects in antigen presentation to NKT cells", J. Immunol, 188, pp.2235~2243 (2012)
- Kang, S. J., "Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules", EMBO J, 21, pp.1650~1660 (2002)
- Hong, S., "The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice", Nat. Med, 7 (2001)
- Kim, H. Y., "NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production", J. Exp. Med, 201, pp.41~47 (2005)
- Jung, S., "Natural killer T cells promote collagen-induced arthritis in DBA", 1 mice, 2009, pp.390, 399~403
- Hong, C., "Application of natural killer T cells in antitumor immunotherapy", Crit. Rev. Immunol, 27, pp.511~525 (2007)
